ALNYLAM PHARMACEUTICALS, INC. Underwriting Agreements
9 Contracts & Agreements
- Underwriting Agreement, dated January 14, 2019, between Alnylam Pharmaceuticals, Inc. and Barclays Capital Inc (Filed With SEC on January 15, 2019)
- Underwriting Agreement, dated November 13, 2017, by and among Alnylam Pharmaceuticals, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives of the... (Filed With SEC on November 14, 2017)
- ALNYLAMPHARMACEUTICALS, INC. 5,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on May 25, 2017)
- ALNYLAMPHARMACEUTICALS, INC. 4,736,842 Shares of Common Stock Underwriting Agreement (Filed With SEC on January 26, 2015)
- ALNYLAM PHARMACEUTICALS, INC. 8,000,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on January 16, 2013)
- ALNYLAM PHARMACEUTICALS, INC. 7,500,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on February 15, 2012)
- EX-1.1 Underwriting Agreement, dated December 12, 2006 (Filed With SEC on December 13, 2006)
- EX-1.1 Amendment to Underwriting Agreement (Filed With SEC on November 4, 2004)
- EX-1.1 UNDERWRITING AGREEMENT (Filed With SEC on May 10, 2004)
